New synbiotic use

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 35/74 (2006.01) A61P 29/00 (2006.01)

Patent

CA 2555151

The invention relates to the use of at least two lactic acid bacterial strains selected from the group comprising Pediococcus pentosaceus 16:1 (LMG P-20608), Leuconostoc mesenteroides 23-77:1 (LMG P-20607), Lactobacillus paracasei subsp paracasei F-19 (LMG P-17806), and Lactobacillus plantarum 2362 (LMG P-20606) for the manufacturing of a formulation for the prevention or treatment of stress-induced inflammatory disorder.

L'invention concerne l'utilisation d'au moins deux souches bactériennes d'acide lactique choisies dans le groupe comprenant Pediococcus pentosaceus 16:1 (LMG p-20608), Leuconostoc mesenteroides 23-77:1 (LMG P-20607), Lactobacillus paracasei subsp paracasei F-19 (LMG P-17806), et lactobacillus plantarum 2362 (LMG P-20606) dans la fabrication d'une formulation destinée à la prévention ou au traitement de trouble inflammatoire induit par le stress.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

New synbiotic use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with New synbiotic use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New synbiotic use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1362417

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.